Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Jan 22, 2021 12:12am
132 Views
Post# 32356821

RE:RE:RE:RE:RE:RE:RE:RE:RE:Insider Transactions Reported this Week

RE:RE:RE:RE:RE:RE:RE:RE:RE:Insider Transactions Reported this Week
GrahamB wrote:

Also invest2-read the post-I didn't say the investor exercised anything
Reread i\the post

The investor(or really speculator since this company doesn't have any profits and is stated in the finacials to have negative working capital-despite what promoters here are saying)
'just gave up his/her/thier money 
 

So let's focus on the net effect- are you saying that the insiders haven't been net  selling?

If so, please show your math 
 



On Jan. 19 RH started by selling 16,338 shares at $0.135 = $2206

He then converted 666,666 debentures into 666,666 shares --- both priced at $0.075 (?)

He then sold 500,000 shares at an average about $0.175  = $87,500

He then exercised 900,000 warrants at $0.10 for 900,000 shares = $90,000 cost

On Jan 20 he again exercised 900,000 warrants at $0.10 for 900,000 shares = $90,000 cost

He then sold 500,000 shares at an average about $0.183  = $91,500

So bottom line he had 166,666 shares balance after the debenture conversion and followed by selling 500,000 shares giving him $87,500 cash. He then put out $180,000 to exercise the 1.8M warrants into shares followed by selling another 500,000 shares for $91,500. i.e. $180,000 out and $179,000 in.

Share wise it appears he is then left with 166,666 + 800,000 = 966,666 shares.

Please go ahead and correct it if there are mistakes.

<< Previous
Bullboard Posts
Next >>